STOCK TITAN

PyroGenesis Announces the Implementation of a NCIB

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
PyroGenesis Canada Inc. has received acceptance from the TSX for its Notice of Intention to implement a Normal Course Issuer Bid (NCIB), allowing the purchase of up to 7,500,000 common shares over a 12-month period. The purchases will be made in accordance with TSX rules and the market price at the time of purchase. The Board of Directors believes this will enhance value and liquidity for shareholders.
Positive
  • PyroGenesis Canada Inc. has received acceptance from the TSX for its Notice of Intention to implement a Normal Course Issuer Bid (NCIB), allowing the purchase of up to 7,500,000 common shares over a 12-month period. The Board of Directors believes this will enhance value and liquidity for shareholders.
Negative
  • None.

MONTREAL, Oct. 04, 2023 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. (http://pyrogenesis.com) (NASDAQ: PYR) (TSX: PYR) (FRA: 8PY), a high-tech Company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, is pleased to announce today that it has received acceptance from the Toronto Stock Exchange (“TSX”) of its Notice of Intention to implement a Normal Course Issuer Bid (“NCIB”).

Pursuant to the NCIB, PyroGenesis may purchase, from time to time, over a period of 12 months starting October 6, 2023, and ending October 5, 2024, up to 7,500,000 common shares (approx. 4,2% of its common shares issued and outstanding as of September 26, 2023). As of September 26, 2023, there were 178,880,395 common shares of PyroGenesis issued and outstanding. On any given day, during the NCIB, PyroGenesis may only purchase up to 23,234 common shares, which is equivalent to 25% of the Average Daily Trading Volume of 92,938 calculated based on the trading volumes on the TSX from April 1, 2023, to September 30, 2023.

Purchases under the NCIB may commence as of October 6, 2023, and will end on the earlier of: (i) October 5, 2024; or (ii) the date on which the Company has purchased the maximum number of common shares to be acquired under the NCIB. All purchases made by the Company will be through Pollitt & Co. Inc. acting on behalf of the Company. The purchases will be made in accordance with the rules of the TSX, through the facilities of the TSX or through alternative Canadian trading systems. The actual number of common shares which will be purchased, and the timing of such purchases, will be determined by the Company, and the price which the Company will pay for the common shares will be the market price at the time of the purchase. The common shares purchased under the NCIB will be cancelled.

The Company's Board of Directors believes that the market price of the Company's common shares may from time to time not reflect the underlying value of the Company, specifically its growth opportunities, and that the proposed purchasing of its common shares is in the best interests of the Company and represents an appropriate use of corporate funds. It is expected that any purchases made by the Company could also enhance value and liquidity for its shareholders.

Of note, the NCIB announced above is further to a previous NCIB that the Company had implemented. Under the previous NCIB, which had started on February 15, 2022, and ended on February 14, 2023, up to 7,500,000 common shares were approved for purchase. No purchases were made under the previous NCIB as management ultimately took the view that it was more appropriate to allocate corporate funds to other company priorities.

About PyroGenesis Canada Inc
PyroGenesis Canada Inc., a high-tech company, is a proud leader in the design, development, manufacture and commercialization of advanced plasma processes and sustainable solutions which reduce greenhouse gases (GHG) and are economically attractive alternatives to conventional “dirty” processes. PyroGenesis has created proprietary, patented and advanced plasma technologies that are being vetted and adopted by multiple multibillion dollar industry leaders in four massive markets: iron ore pelletization, aluminum, waste management, and additive manufacturing. With a team of experienced engineers, scientists and technicians working out of its Montreal office, and its 3,800 m2 and 2,940 m2 manufacturing facilities, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization.  The operations are ISO 9001:2015 and AS9100D certified, having been ISO certified since 1997. For more information, please visit: www.pyrogenesis.com.

Cautionary and Forward-Looking Statements

This press release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of applicable securities laws. In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking statements. Forward-looking statements are not historical facts, nor guarantees or assurances of future performance but instead represent management’s current beliefs, expectations, estimates and projections regarding future events and operating performance.

Forward-looking statements are necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this release, are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. Important factors that could cause actual results to differ, possibly materially, from those indicated by the forward-looking statements include, but are not limited to, the risk factors identified under “Risk Factors” in the Company’s latest annual information form, and in other periodic filings that the Company has made and may make in the future with the securities commissions or similar regulatory authorities, all of which are available under the Company’s profile on SEDAR+ at www.sedarplus.com, or at www.sec.gov. These factors are not intended to represent a complete list of the factors that could affect the Company. However, such risk factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. You should not place undue reliance on forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to publicly update or revise any forward-looking statement, except as required by applicable securities laws.

Neither the Toronto Stock Exchange, its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) nor the NASDAQ Stock Market, LLC accepts responsibility for the adequacy or accuracy of this press release.

For further information please contact:
Rodayna Kafal, Vice President, IR/Comms. and Strategic BD
Phone: (514) 937-0002, E-mail: ir@pyrogenesis.com

RELATED LINK: http://www.pyrogenesis.com/


Pyrogenesis Canada Inc

NASDAQ:PYR

PYR Rankings

PYR Latest News

PYR Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Canada
Montreal